- Home
- KZIA vs SQFT Comparison
KZIA vs SQFT Comparison
Compare KZIA & SQFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZIA
- SQFT
- Stock Information
- Founded
- KZIA 1994
- SQFT 1999
- Country
- KZIA Australia
- SQFT United States
- Employees
- KZIA N/A
- SQFT N/A
- Industry
- KZIA Biotechnology: Pharmaceutical Preparations
- SQFT Real Estate Investment Trusts
- Sector
- KZIA Health Care
- SQFT Real Estate
- Exchange
- KZIA Nasdaq
- SQFT Nasdaq
- Market Cap
- KZIA 5.1M
- SQFT 6.2M
- IPO Year
- KZIA 1999
- SQFT 2020
- Fundamental
- Price
- KZIA $9.76
- SQFT $7.70
- Analyst Decision
- KZIA Strong Buy
- SQFT
- Analyst Count
- KZIA 2
- SQFT 0
- Target Price
- KZIA $14.00
- SQFT N/A
- AVG Volume (30 Days)
- KZIA 671.8K
- SQFT 2.6M
- Earning Date
- KZIA 07-29-2025
- SQFT 08-13-2025
- Dividend Yield
- KZIA N/A
- SQFT N/A
- EPS Growth
- KZIA N/A
- SQFT N/A
- EPS
- KZIA N/A
- SQFT N/A
- Revenue
- KZIA $1,549,158.00
- SQFT $18,260,398.00
- Revenue This Year
- KZIA N/A
- SQFT $23.63
- Revenue Next Year
- KZIA N/A
- SQFT N/A
- P/E Ratio
- KZIA N/A
- SQFT N/A
- Revenue Growth
- KZIA 248983.08
- SQFT N/A
- 52 Week Low
- KZIA $2.86
- SQFT $4.19
- 52 Week High
- KZIA $39.05
- SQFT $23.00
- Technical
- Relative Strength Index (RSI)
- KZIA 63.36
- SQFT 56.47
- Support Level
- KZIA $9.59
- SQFT $6.77
- Resistance Level
- KZIA $12.00
- SQFT $23.00
- Average True Range (ATR)
- KZIA 1.12
- SQFT 1.59
- MACD
- KZIA 0.16
- SQFT 0.36
- Stochastic Oscillator
- KZIA 68.03
- SQFT 17.86
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.
About SQFT Presidio Property Trust Inc.
Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.